Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

von Birgelen, C., Sen, H., Lam, M.K., Danse, P.W., Jessurun, G.A.J., Hautvast, R.W.M., van Houwelingen, G.K., Schramm, A.R., Joe Gin, R.M.T., Louwerenburg, J.W., de Man, F.H.A.F., Stoel, M.G., Löwik, M.M., Linssen, G.C.M., Saöd, S.A.M., Nienhuis, M.B. and Verho, P.M.J. (2013) Third-Generation Zotarolimus-Eluting and Everolimus-Eluting Stents in All-Comer Patients Requiring a Percutaneous Coronary Intervention (DUTCH PEERS): A Randomised, SingleBlind, Multicentre, Non-Inferiority Trial. Lancet, 383, 413-423.
http://dx.doi.org/10.1016/S0140-6736(13)62037-1

has been cited by the following article: